A Pilot Study Evaluating the Safety and Tolerability of Multiple Hyperbaric Oxygen Treatments in Patients with Multiple Myeloma Undergoing High-Dose Therapy and Autologous Hematopoietic Cell Transplants
Key Points
Multiple hyperbaric oxygen treatments are safe and well-tolerated during high-dose therapy.
The study highlights key safety metrics, indicating that adverse effects were minimal in participants.
Observational study with patients undergoing autologous hematopoietic cell transplants and high-dose therapy.
These findings suggest that hyperbaric oxygen therapy may offer supportive treatment options for multiple myeloma patients.